Publications by authors named "Claire Bewshea"

10Publications

Validating the positivity thresholds of drug-tolerant anti-infliximab and anti-adalimumab antibody assays.

Aliment Pharmacol Ther 2020 Nov 23. Epub 2020 Nov 23.

Department of Gastroenterology, Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.16135DOI Listing
November 2020

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.

Gastroenterology 2020 01 7;158(1):189-199. Epub 2019 Oct 7.

Department of Gastroenterology, Royal Devon and Exeter Hospital National Health Service Foundation Trust, Exeter, UK; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.09.041DOI Listing
January 2020

Corrigendum: Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

J Crohns Colitis 2017 12;11(12):1509

Department of Gastroenterology, West Hertfordshire Hospitals NHS Trust, Watford General Hospital, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjx087DOI Listing
December 2017

Infliximab and adalimumab are stable in whole blood clotted samples for seven days at room temperature.

Ann Clin Biochem 2015 Nov 16;52(Pt 6):672-4. Epub 2015 Mar 16.

Department of Blood Sciences, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0004563215580001DOI Listing
November 2015